Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Biohaven Pharmaceutical Q3 EPS $(1.75) Up From $(1.91) YoY

Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(1.75) per share. This is a 8.38 percent increase over losses of $(1.91) per share from the same period last year.
byBill Haddad
November 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(1.75) per share. This is a 8.38 percent increase over losses of $(1.91) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

What’s Going On With Lucid Stock?

By Henry Khederian
August 9, 1:58 PM
Lucid Group Inc (NASDAQ: LCID) shares are trading lower by 3.89% to $6.91 Wednesday afternoon amid overall market weakness. Major indexes are lower as traders continue to assess recent earnings and Moody's recent downgrade of several U.S. banks.

LCID